Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Chiesi USA
AddedFeb 16, 2024
UpdatedJun 18, 2026
Chiesi USA

Chiesi USA

Angel

Chiesi USA, a NC-based specialty pharmaceutical subsidiary of Chiesi Farmaceutici, focuses on hospital and rare disease products.

HQ
Cary, NC, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Founded in Cary, North Carolina, Chiesi USA is a specialty pharmaceutical company dedicated to the commercialization of products for hospitals, rare diseases, and targeted office-based specialties. As a Public Benefit Corporation, Chiesi USA aims to positively impact the communities it serves while meeting the evolving needs of its customers through an entrepreneurial approach. The company is a subsidiary of Chiesi Farmaceutici and employs approximately 300 people.

Chiesi USA has garnered attention for its commitment to corporate citizenship and its focus on niche medical markets. The company benefits from the expertise and resources of its parent organization, Chiesi Farmaceutici. Notable achievements include the successful launch of several specialty pharmaceutical products that address critical needs in healthcare. Through its innovative solutions and community-focused initiatives, Chiesi USA has made a significant impact on both the medical field and the communities it serves.

Chiesi USA - Similar Companies

US Specialty Formulations logo

US Specialty Formulations

Assertio Holdings logo

Assertio Holdings

Chesapeake Therapeutics logo

Chesapeake Therapeutics

Accuitis logo

Accuitis

accuitis.com

Harmony Biosciences logo

Harmony Biosciences

Catalyst Pharmaceuticals logo

Catalyst Pharmaceuticals

catalystpharma.com

Chimerix logo

Chimerix

Manhattan Pharmaceuticals logo

Manhattan Pharmaceuticals

CSR Pharma Group logo

CSR Pharma Group

csrpharmsvcs.com

United Therapeutics logo

United Therapeutics

Cumberland Pharmaceuticals logo

Cumberland Pharmaceuticals

Vertice Pharma logo

Vertice Pharma

Collaborations Pharmaceuticals logo

Collaborations Pharmaceuticals

Novartis Pharma logo

Novartis Pharma

UCB logo

UCB

ucb.com

Chiesi USA - Quick Facts

Who are Chiesi USA's competitors?

Companies similar to Chiesi USA include US Specialty Formulations, Assertio Holdings, Chesapeake Therapeutics and Accuitis.

When was Chiesi USA founded?

Chiesi USA was founded in 2014.

Where is Chiesi USA's headquarters located?

Chiesi USA's headquarters is located in Cary, NC, US.

When was Chiesi USA's last funding round?

Chiesi USA's most recent funding round was for $3k (USD) in August 2020.

How much has Chiesi USA raised to-date?

As of Aug 4, 2020, Chiesi USA has raised a total of $3k (USD).

How many employees does Chiesi USA have?

Chiesi USA has 435 employees as of Feb 4, 2024.

Chiesi USA - Classification

Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthtech
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified